About Peter Bains

Peter is currently Chief Business Officer of MiNA Therapeutics Limited, a private company focused on the development of RNA activation therapeutics. Peter is Non-Executive Chair of ILC Therapeutics, a private UK-based biotechnology company and pioneer in the discovery and development of interferon drugs. Peter is also a Non-Executive Director of Mereo BioPharma Group plc.

Peter has over three decades of experience in the biotech and pharmaceutical industry, which included a 23-year career at GlaxoSmithKline, where he held numerous senior operational and strategic roles. He also served as the Representative Executive Officer and Chief Executive Officer of Sosei Group Corporation, a Tokyo listed biotech company, and Chief Executive Officer of Syngene International, which he successfully took public on the Mumbai Exchanges in 2015.

Peter has a BSc Combined (Honours) in Physiology/Zoology from Sheffield University.

Chair of the Science & Policy Committee
Member of the Audit Committee